The newly identified miR-744/ARHGAP5 axis provides new insight into the progression of NPC, particularly with respect to the regulation mechanism of invasion and migration, and represents a potential therapeutic target for the treatment of NPC. This evidence concerns the gene ARHGAP5 and nasopharyngeal carcinoma.